A phase 2 trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC)
Petrylak, Daniel Peter, Smith, David C., Appleman, Leonard Joseph, Fleming, Mark T., Hussain, Arif, Dreicer, Robert, Sartor, A. Oliver, Shore, Neal D., Vogelzang, Nicholas J., Youssoufian, Hagop, DiPippo, Vincent A., Stambler, Nancy, Huang, Kathleen, Israel, Robert Joseph
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract 2838: Intratumoral-regulated expression of IL-12 as a potential immunotherapeutic strategy for the treatment of breast cancer
Barrett, John A., Sun, Lei, Grigoriadis, Maria, Fulan-Freguia, Christan, Chan, Tim, Fogler, Bill, Humeau, Laurent, Khosravi-Far, Roya, Morgan, Robert A., Youssoufian, Hagop
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 1546: Combined direct intratumoral adenoviral delivery and production of Rheoswitch®-regulated IL-12 and IFNα enhances antitumor activity in lung and breast cancer models
Murugesan, Selva, Chan, Tim, Reed, Charles, Bharathan, Mini, Connelly, Sheila, Fogler, William E., Youssoufian, Hagop, Herberman, Ron
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
MP70-20 A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
Petrylak, Daniel, Smith, David C, Appleman, Leonard J, Fleming, Mark, Hussain, Arif, Dreicer, Robert, Sartor, A. Oliver, Shore, Neil, Vogelzang, Nicholas J, Youssoufian, Hagop, Olson, William, Stambler, Nancy, Huang, Kathleen, Israel, Robert
Published in The Journal of urology (01.04.2014)
Published in The Journal of urology (01.04.2014)
Get full text
Journal Article
A phase II trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC)
Petrylak, Daniel Peter, Smith, David C., Appleman, Leonard Joseph, Fleming, Mark T., Hussain, Arif, Dreicer, Robert, Sartor, A. Oliver, Shore, Neal D., Vogelzang, Nicholas J., Youssoufian, Hagop, Olson, William C., Stambler, Nancy, Huang, Kathleen, Israel, Robert Joseph
Published in Journal of clinical oncology (01.02.2014)
Published in Journal of clinical oncology (01.02.2014)
Get full text
Journal Article
A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining
Wierzbicki, Rafal, Jonker, Derek J., Moore, Malcolm J., Berry, Scott R., Loehrer, Patrick J., Youssoufian, Hagop, Rowinsky, Eric K.
Published in Investigational new drugs (01.02.2011)
Published in Investigational new drugs (01.02.2011)
Get full text
Journal Article
A phase I study of oral darinaparsin in patients (pts) with advanced solid tumors (AST)
Camacho, Luis H., Senzer, Neil N., Harb, Wael A., Barrett, John A, Korth, Christopher Charles, Astl, Dorothea, Jac, Jaroslaw, Youssoufian, Hagop
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
Traina, Tiffany A., Hudis, Clifford, Gonzalez, Joseph, Anthony, Stephen Patrick, Smith, David A., Chandler, Jason Claud, Jac, Jaroslaw, Youssoufian, Hagop, Norton, Larry
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase I open-label study of Ad-RTS-hIL-12, an adenoviral vector engineered to express hIL-12 under the control of an oral activator ligand, in subjects with unresectable stage III/IV melanoma
Linette, Gerald P., Hamid, Omid, Whitman, Eric D., Nemunaitis, John J., Chesney, Jason, Agarwala, Sanjiv S., Starodub, Alexander, Barrett, John A, Marsh, Andrew, Martell, Lori A., Cho, Angela, Reed, Thomas D., Youssoufian, Hagop, Vergara-Silva, Andrea
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Abstract B53: Multicenter phase Ib study of the safety and efficacy of palifosfamide plus carboplatin/etoposide (PaCE) in patients with small cell lung cancer or other selected cancers
Harb, Wael A., Govindan, Ramaswamy, Fisher, William B., Buck, Jill Y., Lewis, Jonathan J., Youssoufian, Hagop, Einhorn, Lawrence H.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
A phase II study of 99m Tc-trofolastat (MIP-1404) SPECT/CT to identify and localize prostate cancer in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) compared to histopathology: An interim analysis
Slawin, Kevin Mark, Ellis, William J., Tenke, Peter, Joniau, Steven, Alekseev, Boris Y., Buzogány, Istvan, Mishugin, Sergey, Klein, Eric A., Karnes, R. Jeffrey, Scherr, Douglas, Yuh, Bertram E., Jarrard, David Frasier, Trabulsi, Edouard John, Stolz, Josef, Babich, John, Youssoufian, Hagop, Stambler, Nancy, Armor, Thomas, Israel, Robert Joseph
Published in Journal of clinical oncology (01.02.2014)
Published in Journal of clinical oncology (01.02.2014)
Get full text
Journal Article
Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor a
Shah, Gaurav D, Loizos, Nick, Youssoufian, Hagop, Schwartz, Jonathan D, Rowinsky, Eric K
Published in Cancer (15.02.2010)
Published in Cancer (15.02.2010)
Get full text
Journal Article
Abstract 4396: Combination of intratumoral regulated IL-12 gene delivery and systemic chemotherapy with Palifosfamide (IPM-Tris) enhances anti-tumor effects in breast cancer (4T1) model
Murugesan, Selva, Fogler, William, Valacer, David, Youssoufian, Hagop, Morgan, Robert A., Herberman, Ronald, Connelly, Shelia, Hart, Susan E., Bharathan, Mini, Chan, Timothy, Shakleya, Diaa, Moreno, Mario, Barrett, John A.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Abnormal Microsomal Detoxification Implicated in Fanconi Anemia Group C by Interaction of the FAC Protein With NADPH Cytochrome P450 Reductase
Kruyt, Frank A.E., Hoshino, Taizo, Liu, Johnson M., Joseph, Pius, Jaiswal, Anil K., Youssoufian, Hagop
Published in Blood (01.11.1998)
Published in Blood (01.11.1998)
Get full text
Journal Article